Based on these molecular markers, breast cancer can be classified into four basic molecular subgroups using panels of immunohistochemical markers (ER, PR, HER2, EGFR and CK5/6) in a similar way to those defined by genetic profiles4, 10, 11, 15. This evidence concerns the gene ERBB2 and breast carcinoma.